SLIDESHOW: Ten Bargains You Can Buy Cheaper Than The Insiders
| This Slide: #1 of 10 |
(1) RAPT Therapeutics Inc (NASDAQ:RAPT) triggered: 07/09/2020
RAPT Therapeutics is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. Co. is engaged in developing highly selective small molecules designed to modulate the critical immune responses underlying these diseases by utilizing its proprietary drug discovery and development engine. Co.'s oncology drug candidate, FLX475, inhibits the migration of immunosuppressive regulatory T cells into tumors. Co.'s inflammation drug candidate, RPT193, inhibits the migration of type 2 T helper cells, into allergically-inflamed tissues.
RAPT — last trade: $25.46 — Recent Insider Buys:
| Purchased | Insider | Title | Shares | Price/Share | Value |
|---|---|---|---|---|---|
| 07/01/2020 | Wendye Robbins | Director | 2,600 | $26.01 | $67,632 |
|
|||||||||||||||||||||
Read full article in a new window: Get An Even Better Deal On RAPT Than Director Robbins Did
Open the RAPT Videos Page (in a new window) »
|
|
Avg. Broker Rec.
|
Strong Buy (4.00 out of 4) 86th percentile
(ranked higher than approx. 86% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |
|
|
